Showing 731-740 of 5910 results for "".
Epi-Off Versus Epi-On: the Conversation Continues
https://modernod.com/topics/corneaanterior-segment/epi-off-versus-epi-on-the-conversation-continues/38954/As epi-on gains traction, optometry may soon have another FDA-approved CXL option.AI-Powered Vision Test Kiosks Are Coming
https://modernod.com/articles/significant-findings/ai-powered-vision-test-kiosks-are-coming/37817/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatCorneal Endothelial Disease Intervention
https://modernod.com/topics/corneaanterior-segment/corneal-endothelial-disease-intervention/38868/A review of current surgical options.Pearls for Prism
https://modernod.com/topics/contact-lenses/pearls-for-prism/38837/Incorporating this feature into contact lenses may be the missing piece in some patients’ management plans.Survey Says …
https://modernod.com/articles/significant-findings/survey-says/37794/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat68. Oh, the Places You’ll Go… as a New Grad ft. Dr. Alexa Hecht
https://modernod.com/podcasts/four-eyes/68-oh-the-places-youll-go-as-a-new-grad-ft-dr-alexa-hecht/37018/Amrit and Deepon sit down with Dr. Alexa Hecht, a new grad Optometrist from the University of Waterloo School of Optometry, to talk about her journey into practicing. Alexa shares the ups and downs of working in multiple practice locations six days a week, and how this work-life “imbalance” took a tViaLase Launches Clinical Trial for Incision-Free Glaucoma Procedure
https://modernod.com/articles/significant-findings/vialase-launches-clinical-trial-for-incision-free-glaucoma-procedure/49095/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuCycloplegic Refraction Shows Benefit Over Non-Cycloplegic Tools
https://modernod.com/articles/significant-findings/cycloplegic-refraction-shows-benefit-over-non-cycloplegic-tools/48965/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuCorneal Therapies Come and Go
https://beta.modernod.com/articles/significant-findings/corneal-therapies-come-and-go/39851/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatCrazy New Info About Presbyopia Drops
https://beta.modernod.com/articles/significant-findings/crazy-new-info-about-presbyopia-drops/39849/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat